Francisco M. Marty

Infectious Disease

75 Francis St
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 161 publications

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.

Journal: Open forum infectious diseases

Published: January 26, 2023

Cytomegalovirus-related Complications and Management in Facial Vascularized Composite Allotransplantation: An International Multicenter Retrospective Cohort Study.

Cytomegalovirus-related Complications and Management in Facial Vascularized Composite Allotransplantation: An International Multicenter Retrospective Cohort Study.

Journal: Transplantation

Published: April 07, 2022

Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States.

Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: April 05, 2022

The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study.

The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study.

Journal: Open forum infectious diseases

Published: April 05, 2022

Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax.

Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax.

Journal: Leukemia & lymphoma

Published: March 15, 2022

Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.

Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.

Journal: Blood advances

Published: March 03, 2022

Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus Reactivation.

Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus Reactivation.

Journal: Transplantation and cellular therapy

Published: February 24, 2022

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.

Journal: The New England journal of medicine

Published: December 22, 2021

Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.

Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 16, 2021

When to change treatment of acute invasive aspergillosis: an expert viewpoint.

When to change treatment of acute invasive aspergillosis: an expert viewpoint.

Journal: The Journal of antimicrobial chemotherapy

Published: September 11, 2021

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 08, 2021

Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.

Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.

Journal: Medical mycology

Published: September 05, 2021

Showing 1-12 of 161

Last Updated: 09/26/2026